Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
-
AbCellera prices $200M public offering of shares and warrants
-
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
-
Thunder Bridge Capital Partners V prices $261M IPO on Nasdaq
-
Thunder Bridge Capital Partners V, Ltd. Announces Pricing of $261 Million Initial Public Offering
-
Orchid Island Capital Announces August 2026 Monthly Dividend and July 31, 2026 RMBS Portfolio Characteristics
-
Securitize Reports Second Quarter 2026 Results
-
Belite Bio (BLTE) Reiterated at Overweight by Cantor Fitzgerald
-
Quantinuum (QNT) Reiterated at Overweight by Cantor Fitzgerald
-
Replimune Group (REPL) Reiterated at Overweight by Cantor Fitzgerald
-
Exodus Movement (EXOD) PT Raised to $15 at Cantor Fitzgerald on Higher EV/Sales Multiple
-
eToro Group (ETOR) PT Lowered to $53 at Cantor Fitzgerald on Lower EBITDA Estimates
-
CoreWeave (CRWV) PT Raised to $178 at Cantor Fitzgerald Amid Strong Demand
-
Londian Wason prices IPO at $22 per ADS, raising $94.3 million
-
Global Copper Foil Leader Londian Wason Announces Pricing of Upsized Initial Public Offering
-
Silence Therapeutics prices $175 million public offering at $13.50 per ADS
-
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
-
AbCellera launches $200M public offering of common stock
-
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Riot Platforms (RIOT) PT Raised to $30 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on USA Rare Earth Inc (USAR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Surgery Partners (SGRY), Highlights Improved Cash Conversion
-
Cantor Fitzgerald Reiterates Neutral Rating on Quantum Computing, Inc. (QUBT)
-
Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO), Updates Estimates
-
Rocket Lab USA (RKLB) PT Raised to $122 at Cantor Fitzgerald Post Q2 Results
-
Cantor Fitzgerald Reiterates Overweight Rating on Archer Aviation Inc. (ACHR) on Recent Acquisitions
-
Stardust Power adds capital markets veteran to its board
-
Stardust Power Appoints Ray Rivers to Board of Directors
-
AST Spacemobile (ASTS) PT Raised to $90 at Cantor Fitzgerald, 'we think it’s clear that ASTS can continue to be a winning equity story'
-
Silence Therapeutics launches $150 million ADS public offering
-
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
-
Global Payments (GPN) PT Raised to $91 at Cantor Fitzgerald
-
Bitdeer launches $1B at-the-market share offering on Nasdaq
-
Cantor Fitzgerald Reiterates Overweight Rating on SanDisk (SNDK)
-
CareTrust REIT (CTRE) PT Raised to $43 at Cantor Fitzgerald
-
Primoris Services Corporation (PRIM) PT Raised to $105 at Cantor Fitzgerald
-
EMCOR Group (EME) PT Lowered to $1,047 at Cantor Fitzgerald
-
Remitly Global Inc (RELY) PT Raised to $30 at Cantor Fitzgerald
-
Fidelity National Information Services (FIS) PT Lowered to $50 at Cantor Fitzgerald
-
Corpay (CPAY) PT Raised to $480 at Cantor Fitzgerald
-
AI Found an Influenza Target That Survives Viral Mutation
-
Evolution Metals appoints former JL MAG CTO to lead magnet production
-
Evolution Metals & Technologies Appoints Industry Veteran Kenji Konishi to Lead Rare Earth Magnet Engineering Production
-
Evolution Metals & Technologies Appoints Industry Veteran Kenji Konishi to Lead Rare Earth Magnet Engineering Production
-
Replimune prices $150M stock offering at $12.06 per share
-
Replimune Announces Pricing of $150 Million Underwritten Offering
-
Braveheart Bio raises $439.9M in upsized Nasdaq IPO
-
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
PFE builds bull case at $26 after earnings beat and insider buys
-
Cantor Fitzgerald Downgrades Serve Robotics (SERV) to Neutral

